New AI systems incorporate physical and mechanistic constraints to improve the accuracy of predicting how chemical reactions will unfold.
AI is increasingly being used in drug discovery to analyze large chemical datasets and identify potential therapeutic compounds. Researchers estimate that the number of potentially useful small molecule compounds is too large for experimental testing alone, leading to increased reliance on computational screening methods.
MIT researchers are developing machine learning models designed to predict the behavior of molecules and chemical reaction pathways. This research focuses on identifying promising drug candidates and improving how chemical reactions are simulated and understood using data-driven methods.
This research incorporates chemical principles such as reaction mechanisms and physical constraints into the AI model. The group has developed models such as ShEPhERD, which predicts molecular interactions with proteins, and FlowER, which models the outcomes of chemical reactions.
The group’s research also extends to automated experimentation, structural analysis, and experimental design, with the goal of creating more efficient workflows for drug discovery. The broader aim, the researchers say, is to improve the realism and accuracy of computational predictions in chemistry.
Why is it important?
AI-driven chemistry significantly reduces the time and cost required to identify viable drug candidates by narrowing down the vast chemical search space that is impossible to evaluate experimentally.
Incorporating chemical principles into machine learning models can also improve reliability, making computational predictions more useful in real-world drug development and potentially accelerating the delivery of new treatments.
Want to know more about AI, technology and digital diplomacy? If so, Ask the chatbot a question!
